Production (Stage)
Outlook Therapeutics, Inc.
OTLK
$1.90
$0.031.60%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -84.00% | -44.94% | -36.19% | -5.00% | 8.25% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -37.04% | -31.67% | 64.60% | 46.02% | 12.03% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -69.18% | -23.16% | -11.50% | 6.04% | 8.92% |
|
|||||
Total Current Assets | -69.18% | -23.16% | -11.50% | 6.04% | 8.92% |
Net Property, Plant & Equipment | 6,675.68% | 1,652.00% | 948.09% | 666.04% | -92.39% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -16.78% | -14.10% | -12.37% | -18.70% | 315.45% |
Total Assets | -67.69% | -21.58% | -10.77% | 5.95% | 9.26% |
|
|||||
Total Accounts Payable | 77.99% | 250.33% | 21.21% | 9.83% | 20.54% |
Total Accrued Expenses | 0.96% | -17.02% | 17.91% | -67.61% | -49.87% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -73.06% | -15.73% | -17.06% | -6.55% | 40.54% |
Total Finance Division Other Current Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Current Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Current Liabilities | -54.10% | 4.93% | -8.94% | -14.77% | 24.24% |
|
|||||
Total Current Liabilities | -54.10% | 4.93% | -8.94% | -14.77% | 24.24% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -96.08% | 31,487.42% | 953,109.68% | 439,655.00% | 1,676,821.69% |
Total Liabilities | -73.33% | 46.21% | 118.02% | 161.79% | 343.92% |
|
|||||
Common Stock & APIC | 17.57% | 4.59% | 3.69% | 3.53% | 3.24% |
Retained Earnings | 3.56% | -9.77% | -16.11% | -20.67% | -36.65% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 75.82% | -106.59% | -406.15% | -1,420.56% | -1,379.94% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 75.82% | -106.59% | -406.15% | -1,420.56% | -1,379.94% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 75.82% | -106.59% | -406.15% | -1,420.56% | -1,379.94% |
|